Browse by author
Lookup NU author(s): Dr R Neely
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Familial hypercholesterolaemia (FH) is under-diagnosed and under-treated, despite clear evidence-based guidelines for identification and management, and the availability of low-cost, generic, high-intensity statin treatment. Genetic cascade testing is the key to early diagnosis, which can help ensure that this treatment is no longer 'too little, too late'. Copyright Sherborne Gibbs Limited.
Author(s): Neely RDG
Publication type: Note
Publication status: Published
Journal: Primary Care Cardiovascular Journal
Year: 2014
Volume: 7
Issue: 1
Pages: 31-35
Print publication date: 01/01/2014
Online publication date: 07/07/2013
Acceptance date: 01/01/1900
ISSN (print): 1756-5138
ISSN (electronic): 1756-5146
Publisher: Sherborne Gibbs Limited
URL: https://www.pccj.eu/browse/editorial/item/4018-the-importance-of-early-diagnosis-how-to-identify-patients-with-fh-for-diagnosis-and-referral.html
DOI: 10.3132/pccj.2013.055
